Abstract:Background: Osteoarthritis (OA) is likely to become an increasing burden in the coming decades. Various agents have been developed to slow the progression of OA, and are collectively known as 'disease-modifying drugs', however, there is still little reliable evidence that such agents will be successful. Dehydroepiandrosterone (DHEA), a sex hormone precursor, has been recently proven as protective agent against OA, but the exact mechanism is still unkown. In the current study, the effects of weekly intra-articular injections of DHEA in preventing the progression of existing cartilage degeneration in an OA rabbit model were evaluated. The aim of the current study is to demonstrate the feature of its disease-modifying efficacy during OA progression.Methods: Thirty male New Zealand white rabbits were used in this study. An anterior cruciate ligament transection (ACLT) model was used to create a progressive OA model in twenty rabbits. The animals were treated with DHEA or a placebo and were necropsied at 9 and 16 weeks. Ten rabbits receiving sham operations served as controls. The articular cartilage of the medial femoral condyle (MFC), lateral femoral condyle (LFC), medial tibial plateau (MTP) and lateral tibial plateau (LTP) was evaluated macroscopically and histologically.Results: In the joints of the sham-operated rabbits, few histological changes were detected on the articular surfaces of the femoral condyles and tibial plateaus. ACLT obviously induced erosive changes on the cartilage surfaces. Compared to the placebo group, the macroscopic and Mankin score analyses demonstrated that the DHEA treatment markedly reduced the cartilage lesions and delayed cartilage degeneration in the four regions of the knee at 9 weeks after operation (macroscopic score: MFC P = 0.013; LFC P = 0.048; MTP P = 0.045; LTP P = 0.02, Mankin score: MFC P = 0.012; LFC P = 0.034; MTP P = 0.016; LTP P = 0.002). At 16 weeks, DHEA demonstrated chondroprotective effects on the lateral compartment of the knee compared to the placebo group, whereas the cartilage degeneration at the medial compartment of the knee did not differ among the groups (macroscopic score: LFC P = 0.046; LTP = 0.034, Mankin score: LFC P = 0.005; LTP P = 0.002).Conclusion: The disease-modifying efficacy of DHEA aganist OA is time-specific and site-dependent. DHEA could be used as a disease-modifying strategy to limit the progression of OA, especially in the middle stage.

Dehydroepiandrosterone reduces accumulation of lipid droplets in primary chicken hepatocytes by biotransformation mediated via the cAMP/PKA-ERK1/2 signaling pathway.

Dehydroepiandrosterone Reduced Lipid Droplet Accumulation Via Inhibiting Cell Proliferation and Improving Mitochondrial Function in Primary Chicken Hepatocytes.

Long-Term Administration of Dehydroepiandrosterone Accelerates Glucose Catabolism Via Activation of Pi3k/Akt-Pfk-2 Signaling Pathway in Rats Fed A High-Fat Diet

Dehydroepiandrosterone reduces preadipocyte proliferation via androgen receptor

Dehydroepiandrosterone: Molecular mechanisms and therapeutic implications in osteoarthritis

A Possible Mechanism in DHEA-mediated Protection Against Osteoarthritis

Dehydroepiandrosterone anti-atherogenesis effect is not via its conversion to estrogen

Dehydroascorbic acid taken up by glucose transporters stimulates estradiol production through inhibition of JNK/c-Jun/AP1 signaling in JAR cells.

(-)-Hydroxycitric Acid Reduced Lipid Droplets Accumulation Via Decreasing Acetyl-Coa Supply and Accelerating Energy Metabolism in Cultured Primary Chicken Hepatocytes

The Chondroprotective Effects of Dehydroepiandrosterone Probably Exerted by Its Conversion to Estradiol

Dehydroepiandrosterone resisted <i>E</i>. <i>Coli</i> O157:H7-induced inflammation <i>via</i> blocking the activation of p38 MAPK and NF-B pathways in mice

Dehydroepiandrosterone and Experimental Osteoarthritis.

Dehydroepiandrosterone inhibits vascular endothelium cell apoptosis induced by endoplasmic reticulum stress via activation of the ERK1/2 and JNK signal pathway

DHA Induces Mitochondria-Mediated 3T3-L1 Adipocyte Apoptosis by Down-Regulation of Akt and ERK

Effect of dehydroepiandrosterone on the immune function of mice in vivo and in vitro.

Ample Evidence: Dehydroepiandrosterone (Dhea) Conversion Into Activated Steroid Hormones Occurs In Adrenal And Ovary In Female Rat

Dehydroepiandrosterone inhibits cell proliferation and improves viability by regulating S phase and mitochondrial permeability in primary rat Leydig cells

The Disease-Modifying Effect of Dehydroepiandrosterone in Different Stages of Experimentally Induced Osteoarthritis: a Histomorphometric Study

Protective Effect of Dhea on Hydrogen Peroxide-Induced Oxidative Damage and Apoptosis in Primary Rat Leydig Cells

Antioxidant Effects of Dehydroepiandrosterone Are Related to Up-regulation of Thioredoxin in SH-SY5Y Cells

Differential Anti-Adipogenic Effects of Eicosapentaenoic and Docosahexaenoic Acids in Obesity.